Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(13%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
25%
Ph phase_1
1
13%
Ph early_phase_1
1
13%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
Phase 1Safety & dosage
1(25.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(4)
Other(3)

Detailed Status

Completed4
unknown3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
100.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (25.0%)
Phase 11 (25.0%)
N/A2 (50.0%)

Trials by Status

completed450%
unknown338%
recruiting113%

Recent Activity

1 active trials
Showing 5 of 8
recruitingphase_1

Intracerebroventricular Administration of CD19-CAR T Cells (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/Mem T-lymphocytes) for the Treatment of Central Nervous System Lymphoma

NCT05625594
unknownnot_applicable

Rhomboid Intercostal and Subserratum Plane Block for Minimally Invasive Esophagectomy

NCT06092944
completedearly_phase_1

Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion

NCT04976257
unknown

Non-invasive Pulmonary Artery Prediction

NCT05622695
unknown

The Significance of Circulating Microvesicles in Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease

NCT05250128
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT05625594Phase 1

Intracerebroventricular Administration of CD19-CAR T Cells (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/Mem T-lymphocytes) for the Treatment of Central Nervous System Lymphoma

Recruiting
NCT06092944Not Applicable

Rhomboid Intercostal and Subserratum Plane Block for Minimally Invasive Esophagectomy

Unknown
NCT04976257Early Phase 1

Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion

Completed
NCT05622695

Non-invasive Pulmonary Artery Prediction

Unknown
NCT05250128

The Significance of Circulating Microvesicles in Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease

Unknown
NCT00844220Not Applicable

Coronary Artery Disease Management Using Multislice Computed Tomography and Magnetic Resonance Imaging

Completed
NCT02443662

Colloid Osmotic Pressure in Patients With Fontan Circulation

Completed
NCT02597413

Evaluation of Post-voiding Residual Urine: a Before-after, Post-partum Study

Completed

All 8 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
8